CXW

CoreCivicA

NYSE / Commercial & Professional Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$27.00

+26.5% vs current

Most likely

Base case

45%

Probability

Target price

$23.00

+7.7% vs current

B-

Bear case

25%

Probability

Target price

$17.00

-20.4% vs current

AI sentiment snapshot

Latest data as of 2026-05-16

AI commentary

Primary-source evidence improved versus the prior baseline because Q1 results, a guidance increase, and Midwest activation are now confirmed, which fits the deterministic prior shifting modestly positive. Still, evidence quality remains only moderate, analyst-revision visibility is limited, and the most important forward variable is still federal occupancy durability rather than a completed rerating. With no usable social-coverage signal in the packet, the setup reads as constructive but still monitoring-oriented rather than outright bullish [#8-K-2026-05-06] [#10-Q-2026-05-07].

RankAlpha Sentiment Codex - 2026-05-16

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-06catalystQ2 occupancy ramp must validate the post-Q1 guidance increaseHigh impact

CoreCivic raised 2026 Adjusted EBITDA guidance to $453.8 million-$461.8 million from $437.0 million-$445.0 million after Q1, helped by the Clinical Solutions Pharmacy acquisition and the Midwest Regional Reception Center opening, but management also said nationwide ICE populations recently decreased because of DHS enforcement redeployments and strategy adjustments. The next quarter needs to show that California City, Diamondback, and Midwest occupancy gains can outweigh that temporary federal-volume softness [#8-K-2026-05-06].

2026-11-15eventCSP integration and capital deployment create a second 2026 proof pointHigh impact

CoreCivic completed the Clinical Solutions Pharmacy acquisition on April 1, 2026 for about $148 million and expects it to add $0.03-$0.05 per share in 2026, while also adding a $100 million incremental term loan on April 10, 2026 to preserve liquidity flexibility. If CSP integrates cleanly and management balances buybacks, acquisitions, and leverage prudently, investors may reward the broader cash-flow story; if integration or leverage optics slip, the setup becomes less attractive [#8-K-2026-05-06] [#10-Q-2026-05-07].

2026-12-31catalystIdle-facility activation and stabilization remain the main earnings engineHigh impact

The Q1 release and 10-Q show earnings were driven by four previously idled facility activations, with California City at 1,817 detainees and Diamondback at 735 as of March 31, 2026, while Midwest began intake on March 12 and is expected to reach stabilized occupancy in Q3 2026. The 10-Q also says CoreCivic still has five idle facilities and roughly 7,000 beds being actively marketed, so sustained utilization is the clearest path to a higher multiple if federal demand holds [#8-K-2026-05-06] [#10-Q-2026-05-07].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-16 • Updated nightlySource: Internal modelMethodology